| Dr Mark Bryniarski, MD | |
|
500 Walters St Ne, Ste 401, Albuquerque, NM 87102-2563 | |
| (505) 727-5910 | |
| (505) 727-5939 |
| Full Name | Dr Mark Bryniarski |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 33 Years |
| Location | 500 Walters St Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528063161 | NPI | - | NPPES |
| 28919826 | Other | CO | MEDICAID GROUP NUMBER |
| DG3723 | Other | CO | RAILROAD MEDICARE GROUP NUMBER |
| 73926337 | Other | CO | MEDICAID PRACTICE NUMBER |
| 31901751 | Medicaid | CO | |
| 348308 | Other | CO | MEDICARE GROUP NUMBER |
| 97-21 | Other | NM | NM LICENSE |
| C810213 | Other | CO | MEDICARE GROUP NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 62063 (Arizona) | Secondary |
| 207T00000X | Neurological Surgery | 97-21 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lovelace Medical Center | Albuquerque, NM | Hospital |
| Lovelace Women's Hospital | Albuquerque, NM | Hospital |
| Lovelace Westside Hospital | Albuquerque, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Medical Associates, Llc | 7214831114 | 291 |
News Archive
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
New findings by researchers at UNC Lineberger Comprehensive Cancer Center suggest that the most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), is probably not a single disease but a set of diseases, each with a distinct underlying molecular disease process.
A nine-month-old boy isn't rolling over, reaching for objects or babbling as he should be. One step his doctor won't likely take right away: have him evaluated by a genetics specialist.
From the 63rd World Health Assembly (WHA) in Geneva, the Associated Press reports on what some "describe as a new strategy to get rid of" polio that focuses on developing solutions to "problems in each country, provides more WHO monitoring, like more teleconferences, and holds governments more accountable." The plans also provide "[n]ew [polio] outbreak response plans," according to the AP.
› Verified 3 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
New findings by researchers at UNC Lineberger Comprehensive Cancer Center suggest that the most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), is probably not a single disease but a set of diseases, each with a distinct underlying molecular disease process.
A nine-month-old boy isn't rolling over, reaching for objects or babbling as he should be. One step his doctor won't likely take right away: have him evaluated by a genetics specialist.
From the 63rd World Health Assembly (WHA) in Geneva, the Associated Press reports on what some "describe as a new strategy to get rid of" polio that focuses on developing solutions to "problems in each country, provides more WHO monitoring, like more teleconferences, and holds governments more accountable." The plans also provide "[n]ew [polio] outbreak response plans," according to the AP.
› Verified 3 days ago
| Entity Name | Southwest Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164491072 PECOS PAC ID: 7214831114 Enrollment ID: O20031121000724 |
News Archive
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
New findings by researchers at UNC Lineberger Comprehensive Cancer Center suggest that the most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), is probably not a single disease but a set of diseases, each with a distinct underlying molecular disease process.
A nine-month-old boy isn't rolling over, reaching for objects or babbling as he should be. One step his doctor won't likely take right away: have him evaluated by a genetics specialist.
From the 63rd World Health Assembly (WHA) in Geneva, the Associated Press reports on what some "describe as a new strategy to get rid of" polio that focuses on developing solutions to "problems in each country, provides more WHO monitoring, like more teleconferences, and holds governments more accountable." The plans also provide "[n]ew [polio] outbreak response plans," according to the AP.
› Verified 3 days ago
| Entity Name | Lovelace Health System Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245798024 PECOS PAC ID: 9739099326 Enrollment ID: O20031210000397 |
News Archive
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
New findings by researchers at UNC Lineberger Comprehensive Cancer Center suggest that the most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), is probably not a single disease but a set of diseases, each with a distinct underlying molecular disease process.
A nine-month-old boy isn't rolling over, reaching for objects or babbling as he should be. One step his doctor won't likely take right away: have him evaluated by a genetics specialist.
From the 63rd World Health Assembly (WHA) in Geneva, the Associated Press reports on what some "describe as a new strategy to get rid of" polio that focuses on developing solutions to "problems in each country, provides more WHO monitoring, like more teleconferences, and holds governments more accountable." The plans also provide "[n]ew [polio] outbreak response plans," according to the AP.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Bryniarski, MD 201 Cedar St Se, Ste 5630, Albuquerque, NM 87106-4920 Ph: (505) 727-5910 | Dr Mark Bryniarski, MD 500 Walters St Ne, Ste 401, Albuquerque, NM 87102-2563 Ph: (505) 727-5910 |
News Archive
Valeant Pharmaceuticals International, Inc. announced that its wholly owned subsidiary, Valeant International (Barbados) SRL, has received notice that the New Drug Submission for colesevelam hydrochloride (colesevelam), an oral bile acid sequestrant for hypercholesterolemia, has been approved by the Canadian regulatory authority Health Canada.
New findings by researchers at UNC Lineberger Comprehensive Cancer Center suggest that the most common form of malignant brain cancer in adults, glioblastoma multiforme (GBM), is probably not a single disease but a set of diseases, each with a distinct underlying molecular disease process.
A nine-month-old boy isn't rolling over, reaching for objects or babbling as he should be. One step his doctor won't likely take right away: have him evaluated by a genetics specialist.
From the 63rd World Health Assembly (WHA) in Geneva, the Associated Press reports on what some "describe as a new strategy to get rid of" polio that focuses on developing solutions to "problems in each country, provides more WHO monitoring, like more teleconferences, and holds governments more accountable." The plans also provide "[n]ew [polio] outbreak response plans," according to the AP.
› Verified 3 days ago
Dr. Gerald Nathan Gold, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1509 Harvard Ct Ne, Albuquerque, NM 87106 Phone: 505-255-0555 | |
Mehrnoush Gorjian, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: Department Of Neurosurgery 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4280 | |
Sheila Rose Eshraghi, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1 University Of New Mexico, Msc10 5615, Albuquerque, NM 87131 Phone: 505-272-3401 | |
Daniel Shibuya, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne, Ste 401, Albuquerque, NM 87102 Phone: 505-727-5910 Fax: 505-727-5939 | |
Dr. James Andrew Botros, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-3401 | |
Paul Turner, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 5-north University Hospital, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-3160 | |
Dr. Chad Douglas Cole, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-0621 |